The iron-regulated metastasis suppressor, Ndrg-1: Identification of novel molecular targets

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1783, Issue 10, 2008, Pages 1981-1992

  Kovacevic, Zaklina ^a   Fu, Dong ^a   Richardson, Des R ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Desferioxamine; Iron; Iron chelator; Metastasis suppressor; Ndrg 1

Indexed keywords

DIPEPTIDYL PEPTIDASE I; IRON; N MYC DOWNSTREAM REGULATED GENE 1 PROTEIN; THIAMINE TRIPHOSPHATASE; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL; CANCER INVASION; COLON CANCER; CONTROLLED STUDY; DRUG TARGETING; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; GENOME ANALYSIS; HUMAN; HUMAN CELL; LUNG CANCER; METASTASIS; METASTASIS INHIBITION; MOLECULAR DYNAMICS; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PLEIOTROPY; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; UPREGULATION;

ANIMALS; CELL ADHESION; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DOWN-REGULATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; IRON; MALE; MODELS, BIOLOGICAL; NEOPLASM METASTASIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROSTATIC NEOPLASMS; RATS; UP-REGULATION;

EID: 50849085751     PISSN: 01674889     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2008.05.016     Document Type: Article

References (70)

1. Welch D.R., and Tomasovic S.P. Implications of tumor progression on clinical oncology. Clin. Exp. Metastasis 3 (1985) 151-188
2. Welch D.R., and Hunter K.W. A new member of the growing family of metastasis suppressors identified in prostate cancer. J. Natl. Cancer Inst. 95 (2003) 839-841
3. Guan R.J., Ford H.L., Fu Y., Li Y., Shaw L.M., and Pardee A.B. Drg-1 as a differentiation-related, putative metastatic suppressor gene in human colon cancer. Cancer. Res. 60 (2000) 749-755
4. Bandyopadhyay S., Pai S.K., Gross S.C., Hirota S., Hosobe S., Miura K., Saito K., Commes T., Hayashi S., Watabe M., and Watabe K. The Drg-1 gene suppresses tumor metastasis in prostate cancer. Cancer Res. 63 (2003) 1731-1736
5. Bandyopadhyay S., Pai S.K., Hirota S., Hosobe S., Takano Y., Saito K., Piquemal D., Commes T., Watabe M., Gross S.C., Wang Y., Ran S., and Watabe K. Role of the putative tumor metastasis suppressor gene Drg-1 in breast cancer progression. Oncogene 23 (2004) 5675-5681
6. Maruyama Y., Ono M., Kawahara A., Yokoyama T., Basaki Y., Kage M., Aoyagi S., Kinoshita H., and Kuwano M. Tumor growth suppression in pancreatic cancer by a putative metastasis suppressor gene Cap43/NDRG1/Drg-1 through modulation of angiogenesis. Cancer Res. 66 (2006) 6233-6242
7. Qu X., Zhai Y., Wei H., Zhang C., Xing G., Yu Y., and He F. Characterization and expression of three novel differentiation-related genes belong to the human NDRG gene family. Mol. Cell. Biochem. 229 (2002) 35-44
8. Zhou R.H., Kokame K., Tsukamoto Y., Yutani C., Kato H., and Miyata T. Characterization of the human NDRG gene family: a newly identified member, NDRG4, is specifically expressed in brain and heart. Genomics 73 (2001) 86-97
9. Kokame K., Kato H., and Miyata T. Homocysteine-respondent genes in vascular endothelial cells identified by differential display analysis. GRP78/BiP and novel genes. J. Biol. Chem. 271 (1996) 29659-29665
10. van Belzen N., Dinjens W.N., Diesveld M.P., Groen N.A., van der Made A.C., Nozawa Y., Vlietstra R., Trapman J., and Bosman F.T. A novel gene which is up-regulated during colon epithelial cell differentiation and down-regulated in colorectal neoplasms. Lab. Invest. 77 (1997) 85-92
11. Zhou D., Salnikow K., and Costa M. Cap43, a novel gene specifically induced by Ni2+ compounds. Cancer Res. 58 (1998) 2182-2189
12. Kalaydjieva L., Gresham D., Gooding R., Heather L., Baas F., de Jonge R., Blechschmidt K., Angelicheva D., Chandler D., Worsley P., Rosenthal A., King R.H., and Thomas P.K. N-myc downstream-regulated gene 1 is mutated in hereditary motor and sensory neuropathy-Lom. Am. J. Hum. Genet. 67 (2000) 47-58
13. Piquemal D., Joulia D., Balaguer P., Basset A., Marti J., and Commes T. Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating and growth arrested cells. Biochim. Biophys. Acta. 1450 (1999) 364-373
14. Shah M.A., Kemeny N., Hummer A., Drobnjak M., Motwani M., Cordon-Cardo C., Gonen M., and Schwartz G.K. Drg1 expression in 131 colorectal liver metastases: correlation with clinical variables and patient outcomes. Clin. Cancer Res. 11 (2005) 3296-3302
15. Stein S., Thomas E.K., Herzog B., Westfall M.D., Rocheleau J.V., Jackson II R.S., Wang M., and Liang P. NDRG1 is necessary for p53-dependent apoptosis. J. Biol. Chem. 279 (2004) 48930-48940
16. Wang Z., Wang F., Wang W.Q., Gao Q., Wei W.L., Yang Y., and Wang G.Y. Correlation of N-myc downstream-regulated gene 1 overexpression with progressive growth of colorectal neoplasm. World J. Gastroenterol. 10 (2004) 550-554
17. Kovacevic Z., and Richardson D.R. The metastasis suppressor, Ndrg-1: a new ally in the fight against cancer. Carcinogenesis 6 (2006) 1982-1994
18. Ellen T., Ke Q., Zhang P., and Costa M. NDRG1, a growth and cancer related gene: regulation of gene expression and function in normal and disease states. Carcinogenesis 29 (2007) 2-8
19. Bandyopadhyay S., Wang Y., Zhan R., Pai S.K., Watabe M., Iiizumi M., Furuta E., Mohinta S., Liu W., Hirota S., Hosobe S., Tsukada T., Miura K., Takano Y., Saito K., Commes T., Piquemal D., Hai T., and Watabe K. The tumor metastasis suppressor gene Drg-1 down-regulates the expression of activating transcription factor 3 in prostate cancer. Cancer Res. 66 (2006) 11983-11990
20. Le N.T., and Richardson D.R. Iron chelators with high antiproliferative activity up-regulate the expression of a growth inhibitory and metastasis suppressor gene: a link between iron metabolism and proliferation. Blood 104 (2004) 2967-2975
21. Dong Z., Arnold R.J., Yang Y., Park M.H., Hrncirova P., Mechref Y., Novotny M.V., and Zhang J.T. Modulation of differentiation-related gene 1 expression by cell cycle blocker mimosine, revealed by proteomic analysis. Mol. Cell. Proteomics 4 (2005) 993-1001
22. Zhang P., Tchou-Wong K.M., and Costa M. Egr-1 mediates hypoxia-inducible transcription of the NDRG1 gene through an overlapping Egr-1/Sp1 binding site in the promoter. Cancer Res. 67 (2007) 9125-9133
23. Buss J.L., Greene B.T., Turner J., Torti F.M., and Torti S.V. Iron chelators in cancer chemotherapy. Curr. Top. Med. Chem. 4 (2004) 1623-1635
24. Whitnall M., Howard J., Ponka P., and Richardson D.R. A class of iron chelators with a wide spectrum of potent antitumor activity that overcomes resistance to chemotherapeutics. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 14901-14906
25. Yu Y., Wong J., Lovejoy D.B., Kalinowski D.S., and Richardson D.R. Chelators at the cancer coalface: desferrioxamine to Triapine and beyond. Clin. Cancer Res. 12 (2006) 6876-6883
26. Kurdistani S.K., Arizti P., Reimer C.L., Sugrue M.M., Aaronson S.A., and Lee S.W. Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. Cancer. Res. 58 (1998) 4439-4444
27. Salnikow K., Blagosklonny M.V., Ryan H., Johnson R., and Costa M. Carcinogenic nickel induces genes involved with hypoxic stress. Cancer Res. 60 (2000) 38-41
28. Chen B., Nelson D.M., and Sadovsky Y. N-myc down-regulated gene 1 modulates the response of term human trophoblasts to hypoxic injury. J. Biol. Chem. 281 (2006) 2764-2772
29. Motwani M., Sirotnak F.M., She Y., Commes T., and Schwartz G.K. Drg1, a novel target for modulating sensitivity to CPT-11 in colon cancer cells. Cancer Res. 62 (2002) 3950-3955
30. Gao J., and Richardson D.R. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents, IV: The mechanisms involved in inhibiting cell-cycle progression. Blood 98 (2001) 842-850
31. Fu D., and Richardson D.R. Iron chelation and regulation of the cell-cycle: two mechanisms of post-transcriptional regulation of the universal cyclin-dependent kinase inhibitor p21CIP1/WAF1 by iron depletion. Blood 110 (2007) 752-761
32. Eibl K.H., Kook D., Priglinger S., Haritoglou C., Yu A., Kampik A., and Welge-Lussen U. Inhibition of human retinal pigment epithelial cell attachment, spreading, and migration by alkylphosphocholines. Invest. Ophthalmol. Vis. Sci. 47 (2006) 364-370
33. Nakashima Y., Kariya Y., Yasuda C., and Miyazaki K. Regulation of cell adhesion and type VII collagen binding by the beta3 chain short arm of laminin-5: effect of its proteolytic cleavage. J. Biochem. 138 (2005) 539-552
34. Richardson D.R., Tran E.H., and Ponka P. The potential of iron chelators of the pyridoxal isonicotinoyl hydrazone class as effective antiproliferative agents. Blood 86 (1995) 4295-4306
35. Takeda T., Go W.Y., Orlando R.A., and Farquhar M.G. Expression of podocalyxin inhibits cell-cell adhesion and modifies junctional properties in Madin-Darby canine kidney cells. Mol. Biol. Cell. 11 (2000) 3219-3232
36. Dunn L.L., Sekyere E., Rahmanto Y., and Richardson D.R. The function of melanotransferrin: a role in proliferation and tumorigenesis. Carcinogenesis 27 (2006) 2157-2169
37. Smyth G.K. Linear models and empirical Bayes methods for assessing differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3 (2004) Article3
38. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 6 (1979) 65-70
39. Bandyopadhyay S., Pai S.K., Hirota S., Hosobe S., Tsukada T., Miura K., Takano Y., Saito K., Commes T., Piquemal D., Watabe M., Gross S., Wang Y., Huggenvik J., and Watabe K. PTEN up-regulates the tumor metastasis suppressor gene Drg-1 in prostate and breast cancer. Cancer Res. 64 (2004) 7655-7660
40. Kopfstein L., and Christofori G. Metastasis: cell-autonomous mechanisms versus contributions by the tumor microenvironment. Cell. Mol. Life. Sci. 63 (2006) 449-468
41. Kachhap S.K., Faith D., Qian D.Z., Shabbeer S., Galloway N.L., Pili R., Denmeade S.R., DeMarzo A.M., and Carducci M.A. The N-Myc down regulated Gene1 (NDRG1) is a Rab4a effector involved in vesicular recycling of E-cadherin. PLoS ONE 2 (2007) e844
42. Lachat P., Shaw P., Gebhard S., van Belzen N., Chaubert P., and Bosman F.T. Expression of NDRG1, a differentiation-related gene, in human tissues. Histochem. Cell. Biol. 118 (2002) 399-408
43. Shasby D.M. Cell-Cell adhesion in lung endothelium. Am. J. Physiol. Lung. Cell. Mol. Physiol. 292 (2007) L593-L607
44. Gomez-Casero E., Navarro M., Rodriguez-Puebla M.L., Larcher F., Paramio J.M., Conti C.J., and Jorcano J.L. Regulation of the differentiation-related gene Drg-1 during mouse skin carcinogenesis. Mol. Carcinog. 32 (2001) 100-109
45. Ouji Y., Yoshikawa M., Shiroi A., and Ishizaka S. Wnt-10b promotes differentiation of skin epithelial cells in vitro. Biochem. Biophys. Res. Commun. 342 (2006) 28-35
46. Kindas-Mugge I., and Trautinger F. Increased expression of the M(r) 27,000 heat shock protein (hsp27) in in vitro differentiated normal human keratinocytes. Cell. Growth Differ. 5 (1994) 777-781
47. Gojo I., Tidwell M.L., Greer J., Takebe N., Seiter K., Pochron M.F., Johnson B., Sznol M., and Karp J.E. Phase I and pharmacokinetic study of Triapine((R)), a potent ribonucleotide reductase inhibitor, in adults with advanced hematologic malignancies. Leuk. Res. 31 (2007) 1173-1181
48. Hirokawa N., and Takemura R. Kinesin superfamily proteins and their various functions and dynamics. Exp. Cell. Res. 301 (2004) 50-59
49. Welch D.R., and Rinker-Schaeffer C.W. What defines a useful marker of metastasis in human cancer?. J. Natl. Cancer Inst. 91 (1999) 1351-1353
50. Najy A.J., Day K.C., and Day M.L. ADAM15 supports prostate cancer metastasis by modulating tumor cell-endothelial cell interaction. Cancer Res. 68 (2008) 1092-1099
51. Waltregny D., Alami Y., Clausse N., de Leval J., and Castronovo V. Overexpression of the homeobox gene HOXC8 in human prostate cancer correlates with loss of tumor differentiation. Prostate 50 (2002) 162-169
52. Ito Y., Arai K., Nozawa R., Yoshida H., Higashiyama T., Takamura Y., Miya A., Kobayashi K., Kuma K., and Miyauchi A. S100A10 expression in thyroid neoplasms originating from the follicular epithelium: contribution to the aggressive characteristic of anaplastic carcinoma. Anticancer. Res. 27 (2007) 2679-2683
53. Shimizu T., Okayama A., Inoue T., and Takeda K. Analysis of gene expression during staurosporine-induced neuronal differentiation of human prostate cancer cells. Oncol. Rep. 14 (2005) 441-448
54. Goding J.W., Grobben B., and Slegers H. Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/phosphodiesterase family. Biochim. Biophys. Acta. 1638 (2003) 1-19
55. Tozawa K., Yamada Y., Kawai N., Okamura T., Ueda K., and Kohri K. Osteopontin expression in prostate cancer and benign prostatic hyperplasia. Urol. Int. 62 (1999) 155-158
56. Kalinowski D.S., and Richardson D.R. The evolution of iron chelators for the treatment of iron overload disease and cancer. Pharmacol. Rev. 57 (2005) 547-583
57. Nurtjahja-Tjendraputra E., Fu D., Phang J.M., and Richardson D.R. Iron chelation regulates cyclin D1 expression via the proteasome: a link to iron deficiency-mediated growth suppression. Blood 109 (2007) 4045-4054
58. Yu Y., Kovacevic Z., and Richardson D.R. Tuning cell cycle regulation with an iron key. Cell. Cycle. 6 (2007) 1982-1994
59. Maguire B.A., and Zimmermann R.A. The ribosome in focus. Cell 104 (2001) 813-816
60. Tu L.C., Yan X., Hood L., and Lin B. Proteomics Analysis of the Interactome of N-myc Downstream Regulated Gene 1 and its interactions with the androgen response program in prostate cancer cells. Mol. Cell. Proteomics 6 (2007) 575-588
61. Cashman J.R. Human flavin-containing monooxygenase: substrate specificity and role in drug metabolism. Curr. Drug Metab. 1 (2000) 181-191
62. Gocheva V., and Joyce J.A. Cysteine cathepsins and the cutting edge of cancer invasion. Cell. Cycle. 6 (2007) 60-64
63. Szyniarowski P., Lakaye B., Czerniecki J., Makarchikov A.F., Wins P., Margineanu I., Coumans B., Grisar T., and Bettendorff L. Pig tissues express a catalytically inefficient 25-kDa thiamine triphosphatase: insight in the catalytic mechanisms of this enzyme. Biochim. Biophys. Acta. 1725 (2005) 93-102
64. Mannervik M. Target genes of homeodomain proteins. Bioessays 21 (1999) 267-270
65. Nykvist P T.K., Viitasalo T., Kapyla J., Jokinen J., Bruckner-Tuderman L., and Heino J. The cell adhesion domain of type XVII collagen promotes integrin-mediated cell spreading by a novel mechanism. J. Biol. Chem. 276 (2001) 38673-38679
66. Guehenneux F., Duret L., Callanan M.B., Bouhas R., Hayette S., Berthet C., Samarut C., Rimokh R., Birot A.M., Wang Q., Magaud J.P., and Rouault J.P. Cloning of the mouse BTG3 gene and definition of a new gene family (the BTG family) involved in the negative control of the cell cycle. Leukemia 11 (1997) 370-375
67. Bando M., Oka M., Kawai K., Obazawa H., Kobayashi S., and Takehana M. NADH binding properties of rabbit lens lambda-crystallin. Mol. Vis. 12 (2006) 692-697
68. Sampath H., and Ntambi J.M. Stearoyl-coenzyme A desaturase 1, sterol regulatory element binding protein-1c and peroxisome proliferator-activated receptor-alpha: independent and interactive roles in the regulation of lipid metabolism. Curr. Opin. Clin. Nutr. Metab. Care. 9 (2006) 84-88
69. Lakaye B., Makarchikov A.F., Wins P., Margineanu I., Roland S., Lins L., Aichour R., Lebeau L., El Moualij B., Zorzi W., Coumans B., Grisar T., and Bettendorff L. Human recombinant thiamine triphosphatase: purification, secondary structure and catalytic properties. Int. J. Biochem. Cell. Biol. 36 (2004) 1348-1364
70. Vasiljeva O., Reinheckel T., Peters C., Turk D., Turk V., and Turk B. Emerging roles of cysteine cathepsins in disease and their potential as drug targets. Curr. Pharm. Des. 13 (2007) 385-401